Altium Capital Management LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 23Value: $41.2MLatest: 2025Q1

Altium Capital Management LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 23 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "NKTR",
  "ALNY",
  "SKYE",
  "AVDL",
  null,
  "LRMR",
  "AVR",
  "CTNM",
  "EPIX",
  "NVNO",
  null,
  "PMN",
  "INBS",
  null,
  null,
  "RZLT",
  "ACOG",
  "PROF",
  "EOLS",
  "KPTI",
  "XENE",
  null,
  "XTNT"
]

Filing Details

13F-HR/A • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 23
Total Value: 41184642
Accession Number: 0001420506-25-000988
Form Type: 13F-HR/A
CIK: altium-capital-management
Manager Name: Altium-Capital-Management

Data Enrichment

78% identified

18 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

23 positions • $41.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

488445206

Shares:1.3M

Value:$9.6M

% of Portfolio:23.4% ($9.6M/$41.2M)

ALNYLAM PHARMACEUTICALS, INC.

ALNY|02043Q107

Shares:25.0K

Value:$6.8M

% of Portfolio:16.4% ($6.8M/$41.2M)

Evolus, Inc.

EOLS|30052C107

Shares:296.2K

Value:$3.6M

% of Portfolio:8.7% ($3.6M/$41.2M)

Xtant Medical Holdings, Inc.

XTNT|98420P308

Shares:7.3M

Value:$3.4M

% of Portfolio:8.3% ($3.4M/$41.2M)

AVADEL PHARMACEUTICALS PLC

AVDL|G29687103

Shares:419.1K

Value:$3.3M

% of Portfolio:8.0% ($3.3M/$41.2M)

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:303.9K

Value:$2.1M

% of Portfolio:5.1% ($2.1M/$41.2M)

Profound Medical Corp.

PROF|74319B502

Shares:360.6K

Value:$2.1M

% of Portfolio:5.1% ($2.1M/$41.2M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:60.3K

Value:$2.0M

% of Portfolio:4.9% ($2.0M/$41.2M)

ESSA Pharma Inc.

EPIX|29668H708

Shares:1.1M

Value:$1.7M

% of Portfolio:4.0% ($1.7M/$41.2M)

Skye Bioscience, Inc.

SKYE|83086J200

Shares:904.9K

Value:$1.4M

% of Portfolio:3.5% ($1.4M/$41.2M)

Alpha Cognition Inc.

ACOG|02074J501

Shares:177.4K

Value:$897.7K

% of Portfolio:2.2% ($897.7K/$41.2M)

Rezolute, Inc.

RZLT|76200L309

Shares:303.9K

Value:$881.5K

% of Portfolio:2.1% ($881.5K/$41.2M)

NEKTAR THERAPEUTICS

NKTR|640268108

Shares:1.1M

Value:$714.9K

% of Portfolio:1.7% ($714.9K/$41.2M)

Anteris Technologies Global Corp.

AVR|03675P102

Shares:168.6K

Value:$613.7K

% of Portfolio:1.5% ($613.7K/$41.2M)

Larimar Therapeutics, Inc.

LRMR|517125100

Shares:273.2K

Value:$587.4K

% of Portfolio:1.4% ($587.4K/$41.2M)

ProMIS Neurosciences Inc.

PMN|74346M406

Shares:574.2K

Value:$399.4K

% of Portfolio:1.0% ($399.4K/$41.2M)

enVVeno Medical Corp

NVNO|29415J106

Shares:123.3K

Value:$324.2K

% of Portfolio:0.8% ($324.2K/$41.2M)

INTELLIGENT BIO SOLUTIONS INC.

INBS|36151G600

Shares:149.3K

Value:$214.9K

% of Portfolio:0.5% ($214.9K/$41.2M)

Karyopharm Therapeutics Inc.

KPTI|48576U205

Shares:49.3K

Value:$184.5K

% of Portfolio:0.4% ($184.5K/$41.2M)

82003F200

Shares:4.0M

Value:$110.4K

% of Portfolio:0.3% ($110.4K/$41.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip488445206)✕	1.3M	QoQ -30.41% (-562.7K) YoY +277.00% (+945.9K)	All Managers (Combined)	$9.6M	23.4% ($9.6M/$41.2M)	QoQ -37.50% (-$5.8M) YoY +386.85% (+$7.7M)
ALNYLAM PHARMACEUTICALS, INC.(ALNYcusip02043Q107)	25.0K	QoQ NEW(+25.0K) YoY NEW(+25.0K)	All Managers (Combined)	$6.8M	16.4% ($6.8M/$41.2M)	QoQ NEW(+$6.8M) YoY NEW(+$6.8M)
Evolus, Inc.(EOLScusip30052C107)	296.2K	QoQ -56.76% (-388.8K) YoY NEW(+296.2K)	All Managers (Combined)	$3.6M	8.7% ($3.6M/$41.2M)	QoQ -52.88% (-$4.0M) YoY NEW(+$3.6M)
Xtant Medical Holdings, Inc.(XTNTcusip98420P308)	7.3M	QoQ -2.19% (-162.4K) YoY -5.16% (-394.9K)	All Managers (Combined)	$3.4M	8.3% ($3.4M/$41.2M)	QoQ +3.77% (-$123.9K) YoY -61.90% (-$5.5M)
AVADEL PHARMACEUTICALS PLC(AVDLcusipG29687103)	419.1K	QoQ -7.36% (-33.3K) YoY NEW(+419.1K)	All Managers (Combined)	$3.3M	8.0% ($3.3M/$41.2M)	QoQ -30.98% (-$1.5M) YoY NEW(+$3.3M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	303.9K	QoQ -9.02% (-30.1K) YoY NEW(+303.9K)	All Managers (Combined)	$2.1M	5.1% ($2.1M/$41.2M)	QoQ -56.65% (-$2.8M) YoY NEW(+$2.1M)
Profound Medical Corp.(PROFcusip74319B502)	360.6K	QoQ -25.65% (-124.4K) YoY NEW(+360.6K)	All Managers (Combined)	$2.1M	5.1% ($2.1M/$41.2M)	QoQ -42.38% (-$1.5M) YoY NEW(+$2.1M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	60.3K	QoQ +540.96% (+50.9K) YoY -82.68% (-287.7K)	All Managers (Combined)	$2.0M	4.9% ($2.0M/$41.2M)	QoQ +448.58% (+$1.7M) YoY -86.50% (-$13.0M)
ESSA Pharma Inc.(EPIXcusip29668H708)	1.1M	QoQ -26.44% (-377.6K) YoY NEW(+1.1M)	All Managers (Combined)	$1.7M	4.0% ($1.7M/$41.2M)	QoQ -35.07% (-$896.5K) YoY NEW(+$1.7M)
Skye Bioscience, Inc.(SKYEcusip83086J200)	904.9K	QoQ -20.55% (-234.1K) YoY NEW(+904.9K)	All Managers (Combined)	$1.4M	3.5% ($1.4M/$41.2M)	QoQ -55.36% (-$1.8M) YoY NEW(+$1.4M)
Alpha Cognition Inc.(ACOGcusip02074J501)	177.4K	QoQ -35.48% (-97.6K) YoY NEW(+177.4K)	All Managers (Combined)	$897.7K	2.2% ($897.7K/$41.2M)	QoQ -44.57% (-$722.0K) YoY NEW(+$897.7K)
Rezolute, Inc.(RZLTcusip76200L309)	303.9K	QoQ -82.05% (-1.4M) YoY NEW(+303.9K)	All Managers (Combined)	$881.5K	2.1% ($881.5K/$41.2M)	QoQ -89.38% (-$7.4M) YoY NEW(+$881.5K)
NEKTAR THERAPEUTICS(NKTRcusip640268108)	1.1M	QoQ -64.95% (-1.9M) YoY NEW(+1.1M)	All Managers (Combined)	$714.9K	1.7% ($714.9K/$41.2M)	QoQ -74.37% (-$2.1M) YoY NEW(+$714.9K)
Anteris Technologies Global Corp.(AVRcusip03675P102)	168.6K	QoQ -77.12% (-568.4K) YoY NEW(+168.6K)	All Managers (Combined)	$613.7K	1.5% ($613.7K/$41.2M)	QoQ -85.07% (-$3.5M) YoY NEW(+$613.7K)
Larimar Therapeutics, Inc.(LRMRcusip517125100)	273.2K	QoQ -31.00% (-122.8K) YoY -60.69% (-421.8K)	All Managers (Combined)	$587.4K	1.4% ($587.4K/$41.2M)	QoQ -61.67% (-$945.1K) YoY -88.86% (-$4.7M)
ProMIS Neurosciences Inc.(PMNcusip74346M406)	574.2K	QoQ -1.22% (-7.1K) YoY NEW(+574.2K)	All Managers (Combined)	$399.4K	1.0% ($399.4K/$41.2M)	QoQ -27.52% (-$151.7K) YoY NEW(+$399.4K)
enVVeno Medical Corp(NVNOcusip29415J106)	123.3K	QoQ -60.24% (-186.7K) YoY NEW(+123.3K)	All Managers (Combined)	$324.2K	0.8% ($324.2K/$41.2M)	QoQ -65.37% (-$612.0K) YoY NEW(+$324.2K)
INTELLIGENT BIO SOLUTIONS INC.(INBScusip36151G600)	149.3K	QoQ NEW(+149.3K) YoY NEW(+149.3K)	All Managers (Combined)	$214.9K	0.5% ($214.9K/$41.2M)	QoQ NEW(+$214.9K) YoY NEW(+$214.9K)
Karyopharm Therapeutics Inc.(KPTIcusip48576U205)	49.3K	QoQ NEW(+49.3K) YoY NEW(+49.3K)	All Managers (Combined)	$184.5K	0.4% ($184.5K/$41.2M)	QoQ NEW(+$184.5K) YoY NEW(+$184.5K)
(cusip82003F200)✕	4.0M	QoQ NEW(+4.0M) YoY NEW(+4.0M)	All Managers (Combined)	$110.4K	0.3% ($110.4K/$41.2M)	QoQ NEW(+$110.4K) YoY NEW(+$110.4K)